Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation.
Johnson SM, Petrassi HM, Palaninathan SK, Mohamedmohaideen NN, Purkey HE, Nichols C, Chiang KP, Walkup T, Sacchettini JC, Sharpless KB, Kelly JW.
Johnson SM, et al. Among authors: kelly jw.
J Med Chem. 2005 Mar 10;48(5):1576-87. doi: 10.1021/jm049274d.
J Med Chem. 2005.
PMID: 15743199